• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名接受腹膜透析的儿童通过胃造口管给予西那卡塞。

Cinacalcet administration by gastrostomy tube in a child receiving peritoneal dialysis.

作者信息

Nichols Kristen R, Knoderer Chad A, Johnston Bethanne, Wilson Amy C

机构信息

Department of Pharmacy Practice, College of Pharmacy and Health Sciences, Butler University, Indianapolis, Indiana ; Department of Pharmacy, Riley Hospital for Children, Indiana University Health, Indianapolis, Indiana.

Department of Pharmacy Practice, College of Pharmacy and Health Sciences, Butler University, Indianapolis, Indiana.

出版信息

J Pediatr Pharmacol Ther. 2014 Jul;19(3):202-5. doi: 10.5863/1551-6776-19.3.202.

DOI:10.5863/1551-6776-19.3.202
PMID:25309151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4187525/
Abstract

A 2-year-old male with chronic kidney disease with secondary hyperparathyroidism developed hypercalcemia while receiving calcitriol, without achieving a serum parathyroid hormone concentration within the goal range. Cinacalcet 15 mg (1.2 mg/kg), crushed and administered via gastrostomy tube, was added to the patient's therapy. This therapy was effective in achieving targeted laboratory parameters in our patient despite instructions in the prescribing information that cinacalcet should always be taken whole.

摘要

一名患有慢性肾脏病伴继发性甲状旁腺功能亢进的2岁男性在接受骨化三醇治疗期间出现高钙血症,且血清甲状旁腺激素浓度未达到目标范围。遂在患者治疗中加用西那卡塞15毫克(1.2毫克/千克),碾碎后经胃造瘘管给药。尽管处方信息中说明西那卡塞应整片服用,但该治疗仍有效使我们的患者达到了目标实验室指标。

相似文献

1
Cinacalcet administration by gastrostomy tube in a child receiving peritoneal dialysis.一名接受腹膜透析的儿童通过胃造口管给予西那卡塞。
J Pediatr Pharmacol Ther. 2014 Jul;19(3):202-5. doi: 10.5863/1551-6776-19.3.202.
2
Evolution of secondary hyperparathyroidism after kidney transplantation in patients receiving cinacalcet on dialysis.接受西那卡塞治疗的透析患者肾移植后继发性甲状旁腺功能亢进的演变
Transplant Proc. 2009 Jul-Aug;41(6):2396-8. doi: 10.1016/j.transproceed.2009.06.073.
3
Comparison between calcitriol and calcitriol plus low-dose cinacalcet for the treatment of moderate to severe secondary hyperparathyroidism in chronic dialysis patients.比较骨化三醇与骨化三醇加小剂量西那卡塞治疗慢性透析患者中重度继发性甲状旁腺功能亢进症。
Nutrients. 2013 Apr 19;5(4):1336-48. doi: 10.3390/nu5041336.
4
Effect of cinacalcet treatment on vascular arterial stiffness among peritoneal dialysis patients with secondary hyperparathyroidism.西那卡塞治疗对继发性甲状旁腺功能亢进腹膜透析患者血管动脉僵硬度的影响。
Nephrology (Carlton). 2014 Jun;19(6):339-44. doi: 10.1111/nep.12223.
5
Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.西那卡塞用于接受血液透析患者的继发性甲状旁腺功能亢进
N Engl J Med. 2004 Apr 8;350(15):1516-25. doi: 10.1056/NEJMoa031633.
6
The use of cinacalcet hinders the diagnosis of parathyroid carcinoma in a chronic dialysis patient: a case report.西那卡塞的使用妨碍了一名慢性透析患者甲状旁腺癌的诊断:病例报告
BMC Nephrol. 2017 Oct 18;18(1):315. doi: 10.1186/s12882-017-0733-0.
7
Clinical pharmacokinetic and pharmacodynamic profile of cinacalcet hydrochloride.盐酸西那卡塞的临床药代动力学和药效学特征。
Clin Pharmacokinet. 2009;48(5):303-11. doi: 10.2165/00003088-200948050-00002.
8
Hypercalcemia of primary hyperparathyroidism was treated by cinacalcet in a patient with liver cirrhosis.西那卡塞用于治疗一名肝硬化患者的原发性甲状旁腺功能亢进引起的高钙血症。
Exp Clin Endocrinol Diabetes. 2009 Mar;117(3):142-5. doi: 10.1055/s-2008-1078741. Epub 2008 Jun 17.
9
Relationship between parathyroid calcium-sensing receptor expression and potency of the calcimimetic, cinacalcet, in suppressing parathyroid hormone secretion in an in vivo murine model of primary hyperparathyroidism.在原发性甲状旁腺功能亢进症的体内小鼠模型中,甲状旁腺钙敏感受体表达与拟钙剂西那卡塞抑制甲状旁腺激素分泌效力之间的关系。
Eur J Endocrinol. 2005 Oct;153(4):587-94. doi: 10.1530/eje.1.02007.
10
Treatment of Persistent Hypercalcemia and Hyperparathyroidism With Cinacalcet After Successful Kidney Transplantation.肾移植成功后使用西那卡塞治疗持续性高钙血症和甲状旁腺功能亢进症。
Transplant Proc. 2016 Jun;48(5):1623-5. doi: 10.1016/j.transproceed.2016.01.044.

引用本文的文献

1
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).KDIGO 2017慢性肾脏病-矿物质和骨异常(CKD-MBD)诊断、评估、预防及治疗临床实践指南更新
Kidney Int Suppl (2011). 2017 Jul;7(1):1-59. doi: 10.1016/j.kisu.2017.04.001. Epub 2017 Jun 21.

本文引用的文献

1
Comparison between calcitriol and calcitriol plus low-dose cinacalcet for the treatment of moderate to severe secondary hyperparathyroidism in chronic dialysis patients.比较骨化三醇与骨化三醇加小剂量西那卡塞治疗慢性透析患者中重度继发性甲状旁腺功能亢进症。
Nutrients. 2013 Apr 19;5(4):1336-48. doi: 10.3390/nu5041336.
2
An open-label study to evaluate a single-dose of cinacalcet in pediatric dialysis subjects.一项评估单次使用西那卡塞治疗儿科透析患者的开放性研究。
Pediatr Nephrol. 2012 Oct;27(10):1953-9. doi: 10.1007/s00467-012-2186-9. Epub 2012 May 26.
3
New therapies: calcimimetics, phosphate binders and vitamin D receptor activators.新疗法:钙敏感受体激动剂、磷酸盐结合剂和维生素 D 受体激动剂。
Pediatr Nephrol. 2010 Apr;25(4):609-16. doi: 10.1007/s00467-010-1462-9. Epub 2010 Feb 12.
4
Middle-term use of Cinacalcet in paediatric dialysis patients.儿童透析患者中西那卡塞的中期使用。
Pediatr Nephrol. 2010 Jan;25(1):143-8. doi: 10.1007/s00467-009-1294-7. Epub 2009 Oct 17.
5
Cinacalcet for secondary hyperparathyroidism in children with end-stage renal disease.西那卡塞用于终末期肾病儿童的继发性甲状旁腺功能亢进症
Pediatr Nephrol. 2008 Oct;23(10):1823-9. doi: 10.1007/s00467-008-0810-5. Epub 2008 May 27.
6
Cinacalcet is efficacious in pediatric dialysis patients.西那卡塞对小儿透析患者有效。
Pediatr Nephrol. 2008 Oct;23(10):1817-22. doi: 10.1007/s00467-007-0742-5. Epub 2008 Feb 21.
7
Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.静脉注射帕立骨化醇治疗血液透析儿童继发性甲状旁腺功能亢进症。
Am J Kidney Dis. 2007 Jun;49(6):814-23. doi: 10.1053/j.ajkd.2007.03.008.
8
Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis.静脉注射骨化三醇治疗血液透析儿童的甲状旁腺功能亢进症。
Pediatr Nephrol. 2005 May;20(5):622-30. doi: 10.1007/s00467-004-1792-6. Epub 2005 Mar 23.
9
Are new vitamin D analogues in renal bone disease superior to calcitriol?治疗肾性骨病的新型维生素D类似物是否优于骨化三醇?
Pediatr Nephrol. 2005 Mar;20(3):393-8. doi: 10.1007/s00467-004-1788-2. Epub 2005 Feb 3.
10
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.慢性肾脏病骨代谢与疾病的K/DOQI临床实践指南
Am J Kidney Dis. 2003 Oct;42(4 Suppl 3):S1-201.